JP2023540545A5 - - Google Patents

Info

Publication number
JP2023540545A5
JP2023540545A5 JP2023514994A JP2023514994A JP2023540545A5 JP 2023540545 A5 JP2023540545 A5 JP 2023540545A5 JP 2023514994 A JP2023514994 A JP 2023514994A JP 2023514994 A JP2023514994 A JP 2023514994A JP 2023540545 A5 JP2023540545 A5 JP 2023540545A5
Authority
JP
Japan
Prior art keywords
functional variant
seq
sequence
synthetic
vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023514994A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023540545A (ja
Filing date
Publication date
Priority claimed from GBGB2013940.8A external-priority patent/GB202013940D0/en
Application filed filed Critical
Publication of JP2023540545A publication Critical patent/JP2023540545A/ja
Publication of JP2023540545A5 publication Critical patent/JP2023540545A5/ja
Pending legal-status Critical Current

Links

JP2023514994A 2020-09-04 2021-09-03 調節核酸配列 Pending JP2023540545A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB2013940.8A GB202013940D0 (en) 2020-09-04 2020-09-04 Regulatory nucleic acid sequences
GB2013940.8 2020-09-04
PCT/GB2021/052273 WO2022049385A1 (en) 2020-09-04 2021-09-03 Regulatory nucleic acid sequences

Publications (2)

Publication Number Publication Date
JP2023540545A JP2023540545A (ja) 2023-09-25
JP2023540545A5 true JP2023540545A5 (enExample) 2024-09-03

Family

ID=72841262

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023514994A Pending JP2023540545A (ja) 2020-09-04 2021-09-03 調節核酸配列

Country Status (8)

Country Link
US (1) US20230321279A1 (enExample)
EP (1) EP4208207A1 (enExample)
JP (1) JP2023540545A (enExample)
CN (1) CN116457026A (enExample)
AU (1) AU2021336754A1 (enExample)
CA (1) CA3193489A1 (enExample)
GB (1) GB202013940D0 (enExample)
WO (1) WO2022049385A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119256090A (zh) * 2022-03-25 2025-01-03 阿斯克肋匹奥生物制药公司 用于治疗帕金森病的方法和组合物

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
FR2640638B1 (fr) 1988-12-20 1991-02-15 Commissariat Energie Atomique Bioreacteur et dispositif pour la culture de cellules animales
US5194376A (en) 1989-02-28 1993-03-16 University Of Ottawa Baculovirus expression system capable of producing foreign gene proteins at high levels
US5478745A (en) 1992-12-04 1995-12-26 University Of Pittsburgh Recombinant viral vector system
EP0733103B1 (en) 1993-11-09 2004-03-03 Targeted Genetics Corporation Generation of high titers of recombinant aav vectors
US6204059B1 (en) 1994-06-30 2001-03-20 University Of Pittsburgh AAV capsid vehicles for molecular transfer
US5872005A (en) 1994-11-03 1999-02-16 Cell Genesys Inc. Packaging cell lines for adeno-associated viral vectors
US5756283A (en) 1995-06-05 1998-05-26 The Trustees Of The University Of Pennsylvania Method for improved production of recombinant adeno-associated viruses for gene therapy
US6281010B1 (en) 1995-06-05 2001-08-28 The Trustees Of The University Of Pennsylvania Adenovirus gene therapy vehicle and cell line
US5622856A (en) 1995-08-03 1997-04-22 Avigen High efficiency helper system for AAV vector production
JPH11514853A (ja) 1995-09-08 1999-12-21 ジエンザイム コーポレイション 遺伝子治療のための改良されたａａｖベクター
DE19608753C1 (de) 1996-03-06 1997-06-26 Medigene Gmbh Transduktionssystem und seine Verwendung
CA2264482A1 (en) 1996-09-06 1998-03-12 The Trustees Of The University Of Pennsylvania An inducible method for production of recombinant adeno-associated viruses utilizing t7 polymerase
EP0933997A4 (en) 1996-09-06 2000-08-16 Chiron Corp METHODS AND COMPOSITIONS FOR LIVER-SPECIFIC ADMINISTRATION OF THERAPEUTIC MOLECULES USING RECOMBINANT AAV VECTORS
US7732129B1 (en) 1998-12-01 2010-06-08 Crucell Holland B.V. Method for the production and purification of adenoviral vectors
EP0968284B1 (en) 1996-11-20 2006-12-13 Introgen Therapeutics, Inc. An improved method for the production and purification of adenoviral vectors
FR2756297B1 (fr) 1996-11-22 1999-01-08 Centre Nat Rech Scient Procede de production de virus recombinants
US6207455B1 (en) 1997-05-01 2001-03-27 Lung-Ji Chang Lentiviral vectors
US6156303A (en) 1997-06-11 2000-12-05 University Of Washington Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom
US6566118B1 (en) 1997-09-05 2003-05-20 Targeted Genetics Corporation Methods for generating high titer helper-free preparations of released recombinant AAV vectors
US6995006B2 (en) 1997-09-05 2006-02-07 Targeted Genetics Corporation Methods for generating high titer helper-free preparations of released recombinant AAV vectors
JP2001517454A (ja) 1997-09-19 2001-10-09 ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア 組換えアデノ随伴ウイルスの産生に有用な方法および細胞株
WO1999014354A1 (en) 1997-09-19 1999-03-25 The Trustees Of The University Of The Pennsylvania Methods and vector constructs useful for production of recombinant aav
ATE298371T1 (de) 1997-09-24 2005-07-15 Univ California Nicht-primaten lentivirale vektoren und verpackungssysteme
US5994136A (en) 1997-12-12 1999-11-30 Cell Genesys, Inc. Method and means for producing high titer, safe, recombinant lentivirus vectors
EP0924298A1 (en) 1997-12-18 1999-06-23 Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) Protein expression in baculovirus vector expression systems
AU2898299A (en) 1998-03-04 1999-09-20 Onyx Pharmaceuticals, Inc. Baculovirus expression system and method for high throughput expression of genetic material
ATE286138T1 (de) 1998-03-20 2005-01-15 Univ Pennsylvania Zusammensetzungen und verfahren zur helfer-freien herstellung von rekombinante adeno-assoziierten viren
US6953690B1 (en) 1998-03-20 2005-10-11 The Trustees Of The University Of Pennsylvania Compositions and methods for helper-free production of recombinant adeno-associated viruses
US20030017138A1 (en) 1998-07-08 2003-01-23 Menzo Havenga Chimeric adenoviruses
EP1135468B1 (en) 1998-11-10 2010-01-06 University Of North Carolina At Chapel Hill Virus vectors and methods of making and administering the same
US7262049B2 (en) 1999-03-16 2007-08-28 Dana-Farber Cancer Institute, Inc. Pseudotyped lentiviral vectors and uses thereof
US6258595B1 (en) 1999-03-18 2001-07-10 The Trustees Of The University Of Pennsylvania Compositions and methods for helper-free production of recombinant adeno-associated viruses
JP4693244B2 (ja) 1999-03-18 2011-06-01 ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア 組換えアデノ随伴ウイルスのヘルパー無しの生産のための組成物および方法
ATE519854T1 (de) 1999-05-17 2011-08-15 Crucell Holland Bv Rekombinantes adenovirus auf basis von serotyp 48 (ad48).
WO2003104467A1 (en) 2002-04-25 2003-12-18 Crucell Holland B.V. Means and methods for the production of adenovirus vectors
JP2003501067A (ja) 1999-06-02 2003-01-14 トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア ヘルパーウイルスを要求する組み換えウイルス産生のために有用な組成物及び方法
US6365394B1 (en) 1999-09-29 2002-04-02 The Trustees Of The University Of Pennsylvania Cell lines and constructs useful in production of E1-deleted adenoviruses in absence of replication competent adenovirus
WO2001023001A2 (en) 1999-09-29 2001-04-05 The Trustees Of The University Of Pennsylvania Rapid peg-modification
ES2337429T3 (es) 1999-10-11 2010-04-23 Institut Pasteur Vectores lentivirales para la preparacion de composiciones inmunoterapeuticas.
GB0024550D0 (enExample) 2000-10-06 2000-11-22 Oxford Biomedica Ltd
US7749492B2 (en) 2001-01-05 2010-07-06 Nationwide Children's Hospital, Inc. AAV vectors and methods
CA2462628C (en) 2001-10-02 2019-08-20 Institut Clayton De La Recherche Restricted expression lentiviral vectors
JP4559429B2 (ja) 2003-05-21 2010-10-06 ジェンザイム・コーポレーション 空キャプシドを実質的に含まない組換えａａｖビリオン調製物を生成するための方法
EP1486567A1 (en) 2003-06-11 2004-12-15 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Improved adeno-associated virus (AAV) vector for gene therapy
PL2657248T3 (pl) 2003-06-19 2017-09-29 Genzyme Corporation Wiriony AAV o zmniejszonej immunoreaktywności i ich zastosowanie
WO2005001103A2 (en) 2003-06-20 2005-01-06 The Trustees Of The University Of Pennsylvania Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses
US7291498B2 (en) 2003-06-20 2007-11-06 The Trustees Of The University Of Pennsylvania Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses
US9441244B2 (en) 2003-06-30 2016-09-13 The Regents Of The University Of California Mutant adeno-associated virus virions and methods of use thereof
US8106180B2 (en) 2003-08-07 2012-01-31 Whitehead Institute For Biomedical Research Methods and products for expression of micro RNAs
US20050142581A1 (en) 2003-09-04 2005-06-30 Griffey Richard H. Microrna as ligands and target molecules
WO2005056761A2 (en) 2003-12-05 2005-06-23 Massachusetts Institute Of Technology REAGENTS AND METHODS FOR IDENTIFICATION OF RNAi PATHWAY GENES AND CHEMICAL MODULATORS OF RNAi
US20060166363A1 (en) 2004-01-27 2006-07-27 Sergei Zolotukhin Modified baculovirus expression system for production of pseudotyped rAAV vector
KR100614827B1 (ko) 2004-05-06 2006-08-25 재단법인서울대학교산학협력재단 양방향 은닉 마코프 모델을 이용한 완숙한마이크로알엔에이 위치예측방법 및 이를 구현하기 위한컴퓨터 프로그램을 기록한 저장매체
US7427396B2 (en) 2004-06-03 2008-09-23 Genzyme Corporation AAV vectors for gene delivery to the lung
US7632509B2 (en) 2005-07-19 2009-12-15 Biosante Pharmaceuticals, Inc. Methods to express recombinant proteins from lentiviral vectors
US8895715B2 (en) * 2008-05-09 2014-11-25 The University Of British Columbia S100B mini-promoters
EA019928B1 (ru) 2008-11-03 2014-07-30 Круселл Холланд Б.В. Способ получения аденовирусных векторов
WO2013004716A1 (en) * 2011-07-04 2013-01-10 Universität Basel Peptide beads
EP2771455B1 (en) 2011-10-28 2016-10-05 The University of North Carolina At Chapel Hill Cell line for production of adeno-associated virus
ES2926774T3 (es) 2013-03-15 2022-10-28 Univ North Carolina Chapel Hill Métodos y composiciones para vectores AAV de doble unión de glicano
US10577627B2 (en) 2014-06-09 2020-03-03 Voyager Therapeutics, Inc. Chimeric capsids
US11352647B2 (en) * 2016-08-17 2022-06-07 The Broad Institute, Inc. Crispr enzymes and systems
US11512327B2 (en) 2017-08-03 2022-11-29 Voyager Therapeutics, Inc. Compositions and methods for delivery of AAV
GB201717524D0 (en) * 2017-10-25 2017-12-06 Autolus Ltd Vectors
WO2019161304A1 (en) * 2018-02-15 2019-08-22 Duke University Gene editing using homology-independent universal genome engineering technology
EP3781174A4 (en) 2018-04-09 2022-01-26 Allen Institute RESCUE OF VOLTAGE CONTROLLED SODIUM CHANNEL FUNCTION IN INHIBITORY NEURONS
US12467064B2 (en) 2018-10-08 2025-11-11 Allen Institute Artificial expression constructs for selectively modulating gene expression in interneurons
JP7590962B2 (ja) 2018-11-05 2024-11-27 アレン インスティテュート 皮質興奮性ニューロンにおける遺伝子発現を選択的に調節するための人工発現構築物

Similar Documents

Publication Publication Date Title
Lundstrom Viral vectors in gene therapy: where do we stand in 2023?
El Andari et al. Semirational bioengineering of AAV vectors with increased potency and specificity for systemic gene therapy of muscle disorders
Nitta et al. Minimal Purkinje cell-specific PCP2/L7 promoter virally available for rodents and non-human primates
McLean et al. Widespread neuron-specific transgene expression in brain and spinal cord following synapsin promoter-driven AAV9 neonatal intracerebroventricular injection
JP2022091989A (ja) ウイルスベクター産生系
Maes et al. Targeting microglia with lentivirus and AAV: Recent advances and remaining challenges
JP2008538174A5 (enExample)
JP2021519791A (ja) 増強されたヒト膵臓トロピズムを有する新規な組換えアデノ随伴ウイルスキャプシド
US20240336935A1 (en) Self-inactivating lentiviral vector comprising a foxp3 expression cassette
Li et al. Production of lentiviral vectors for transducing cells from the central nervous system
IL320371A (en) Gene therapy for patients with fanconi anemia
JP7523357B2 (ja) ウイルスベクター産生
Aurélie et al. Lentiviral vectors: a powerful tool to target astrocytes in vivo
CN110106203A (zh) 一种新型hbb过表达载体及其设计方法和应用
JP2023509118A5 (enExample)
US20250235480A1 (en) Vectors combining anti-sickling beta-as3-globin with anti bcel11a shrnamir to treat beta-hemoglobinopathies
JP2022507828A5 (enExample)
KR20230129169A (ko) 유전자 치료를 위한 프로토파보바이러스 및 테트라파보바이러스조성물 및 방법
Kuroda et al. A comparative analysis of constitutive and cell‐specific promoters in the adult mouse hippocampus using lentivirus vector‐mediated gene transfer
JP2023544633A (ja) 治療における使用のためのｒａｇ１の置き換え
White et al. A molecular toolbox for rapid generation of viral vectors to up-or down-regulate neuronal gene expression in vivo
Okada et al. Robust long-term transduction of common marmoset neuromuscular tissue with rAAV1 and rAAV9
US8278284B2 (en) Therapeutic agents for diseases associated with apoptotic degeneration in ocular tissue cells that use SIV-PEDF vectors
US20100048678A1 (en) Nucleic acids and polypeptides that are useful in controlling neuronal regeneration
JP2025511192A (ja) 網膜神経節細胞の再生を刺激する方法